Explor&d Translational Medicine

Eli Lilly Eli Lilly · Pharma · Shang Hai-上海, China

This role is for a Director of ExploR&D Translational Medicine at Eli Lilly, focusing on the medical strategy and oversight for drug development programs. The incumbent will lead early-phase clinical development, work with external biotech companies and internal experts, and be responsible for medical and safety leadership from candidate selection to proof-of-concept. Key tasks include constructing and executing clinical development plans, integrating scientific concepts, evaluating literature, providing medical leadership for clinical plans, and ensuring compliance with regulations and GCP.

What you'd actually do

  1. For assigned assets, the incumbent is accountable for the medical and safety leadership for all phases of drug development from candidate selection to proof-of-concept readout.
  2. Works with a multidisciplinary team to construct and execute a sound clinical development plan to develop and test key scientific hypotheses, discharge risks regarding asset safety and efficacy, and enable effective decision-making related to asset development.
  3. Partner with the project team leader who holds accountability for the scientific strategy and overall program management, and other cross functional experts to develop, consult on, and/or execute development plans.
  4. Works with toxicology and pharmacokinetics teams, especially for First-in-Human (FIH) assets, in establish starting doses, dose ranges and in interpreting emerging human PK/PD data to inform dose escalation and dose regimen selection for proof-of-concept studies.
  5. Author, review and approve key documents, including protocols, risk profiles, informed consent documents, clinical study reports, and disclosure of research results.

Skills

Required

  • Medical strategy development
  • Clinical development planning
  • Drug development lifecycle management
  • Safety assessment and management
  • Scientific literature evaluation
  • Cross-functional team collaboration
  • Regulatory document authoring and review
  • Pharmacology
  • Pharmacokinetics (PK)
  • Pharmacodynamics (PD)
  • Toxicology
  • Good Clinical Practice (GCP)

Nice to have

  • Experience with external biotechnology companies and venture capital funds
  • Experience in early phase clinical development
  • Therapeutic area expertise
  • Biomarker strategy
  • Dose escalation
  • First-in-Human (FIH) studies

What the JD emphasized

  • medical strategy
  • medical oversight
  • drug development
  • clinical development
  • safety leadership
  • scientific concepts
  • medical and scientific literature
  • safety management plans
  • risk management
  • GCP